Skip to main content
TipRanks
Go Ultimate75% OFF

Miahelsa Holdings Corporation (7129) AI Stock Analysis

0 Followers
JP:7129

Miahelsa Holdings Corporation

(TSE/TYO:7129)

Select Model
Rating:55Neutral
Price Target:JPY 1,144.00â–²(2.05% Upside)
Action:reiterated
Date:11/18/26

Overall score is driven primarily by steady revenue growth and generally positive cash generation, offset by thin/volatile profitability and a leveraged balance sheet. Technically, the stock’s weak positioning below major moving averages weighs on the score, while a reasonable P/E and moderate dividend yield provide some support.

Positive Factors
Steady Revenue GrowthRevenue expansion across several years indicates resilient demand and continued business activity rather than a single-period benefit. Sustained top-line growth can support operating scale, preserve investment capacity, and provide a foundation for improving earnings over the next several quarters.
Negative Factors
Thin, Volatile ProfitabilityLow and inconsistent profitability limits the company’s ability to turn revenue growth into durable shareholder returns. Near break-even performance also leaves less room to absorb operating pressures, fund expansion internally, or reduce debt while maintaining business investment.

Miahelsa Holdings Corporation (7129) vs. iShares MSCI Japan ETF (EWJ)

-5%0%5%10%15%20%25%30%JP:7129+2.51%EWJ+14.66%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 3.14B
Dividend Yield
2.69%
Average Volume (3M)
2,730
Price to Earnings (P/E)
15.1
Beta (1Y)
0.11
Revenue Growth
4.13%
EPS Growth
-38.70%
Country
Japan
Employees
1,838
Sector
General
Sector Strength
55
Industry
Medical - Pharmaceuticals

Miahelsa Holdings Corporation Business Overview & Revenue Model

Company Description

Miahelsa Holdings Corporation, based in Tokyo, Japan, operates a diverse portfolio of services primarily encompassing the pharmaceutical, childcare, and elder care sectors. In its pharmaceutical segment, the company manages dispensing pharmacies and...

Miahelsa Holdings Corporation Financial Statement Overview

Summary

Revenue has expanded steadily (about ¥19.5B in 2022 to ~¥24.9B in 2026) and operating cash flow is consistently positive with mostly positive free cash flow. However, profitability is thin and volatile (near break-even in 2024, only modest profits in 2025–2026), and leverage is a notable constraint with debt sizable versus equity and increasing in 2026.

Income Statement

56Neutral

Balance Sheet

48Neutral

Cash Flow

62Positive
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue25.11B24.85B23.83B22.72B22.25B19.51B
Gross Profit2.69B2.67B2.39B2.16B2.01B1.90B
EBITDA1.38B1.07B1.15B748.69M1.03B1.09B
Net Income177.63M200.85M299.87M5.53M209.58M291.57M
Balance Sheet
Total Assets13.17B15.59B13.28B13.81B14.14B14.21B
Cash, Cash Equivalents and Short-Term Investments2.98B4.52B1.63B1.90B1.27B1.12B
Total Debt2.94B5.86B3.37B4.41B4.98B5.25B
Total Liabilities9.28B11.68B9.48B10.50B10.80B11.00B
Stockholders Equity3.89B3.91B3.79B3.31B3.34B3.20B
Cash Flow
Free Cash Flow0513.78M500.49M1.29B481.99M-3.21M
Operating Cash Flow0905.96M1.01B1.59B1.02B918.91M
Investing Cash Flow0-363.87M-455.50M-336.08M-556.76M-2.53B
Financing Cash Flow02.41B-853.40M-610.32M-368.67M2.01B

Miahelsa Holdings Corporation Technical Analysis

Technical Analysis SentimentNegative
Last Price1121.00

Price Trends

50DMA1136.69Negative
100DMA1136.47Negative
200DMA1133.73Negative

Market Momentum

MACD-0.09Negative
RSI46.15Neutral
STOCH35.31Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7129, the sentiment is Negative. The current price of 1121.00 is below the 20-day moving average (MA) of 1124.75, below the 50-day MA of 1136.69, and below the 200-day MA of 1133.73, indicating a bearish trend. The MACD of -0.09 indicates Negative momentum. The RSI at 46.15 is Neutral, neither overbought nor oversold. The STOCH value of 35.31 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7129.

Miahelsa Holdings Corporation Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

JP:7129 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:9220JP:922079OutperformJPY 3.03B6.85―3.46%5.71%10.34%
JP:6062JP:606273OutperformJPY 64.01B14.43―2.19%5.50%45.42%
JP:2373JP:237361NeutralJPY 5.23B18.30―4.37%4.76%-52.55%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
JP:7129JP:712955NeutralJPY 3.13B15.14―2.69%4.13%-38.70%
JP:2425JP:242555NeutralJPY 2.48B28.24―3.36%-3.64%-66.52%

* General Sector Average

Performance Comparison

0%20%40%60%JP:7129JP:2373JP:2425JP:6062JP:9220Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:7129 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:7129Miahelsa Holdings Corporation1121.0018.721.70%
JP:2373Care Twentyone Corporation387.00-38.38-9.02%
JP:2425Care Service Co., Ltd.659.00-99.22-13.09%
JP:6062Charm Care Corporation1963.00791.1967.52%
JP:9220FB CARE SERVICE CO.,LTD.1254.0084.077.19%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 17, 2026